Advertisement

Topics

48 drugs may be eligible for priority review in China

06:38 EDT 10 Aug 2018 | SmartBrief

A list of 48 drugs that could be eligible for priority review status was released by China's Center for Drug Evaluation.  -More

Original Article: 48 drugs may be eligible for priority review in China

NEXT ARTICLE

More From BioPortfolio on "48 drugs may be eligible for priority review in China"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...